Cesca Therapeutics

Cesca Therapeutics is a regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. The Company’s device division, ThermoGenesis Corp., provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca’s clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets.

Company Growth (employees)
Rancho Cordova, US
Size (employees)
95 (est)
Cesca Therapeutics was founded in 1986 and is headquartered in Rancho Cordova, US

Cesca Therapeutics Office Locations

Cesca Therapeutics has offices in Rancho Cordova, Gurgaon and Wuxi Shi
Gurgaon, IN (HQ)
857 Udyog Vihar Phase V
Rancho Cordova, US (HQ)
2711 Citrus Rd
Wuxi Shi, CN
800 Jie Fang Dong Lu

Cesca Therapeutics Financials and Metrics

Cesca Therapeutics Financials

Cesca Therapeutics's revenue was reported to be $11.9 m in FY, 2016

Revenue (Q3, 2017)

3.3 m

Gross profit (Q3, 2017)

1.4 m

Gross profit margin (Q3, 2017), %


Net income (Q3, 2017)

(2.1 m)

EBIT (Q3, 2017)

(2.1 m)

Market capitalization (13-Nov-2017)

31.9 m

Cash (31-Mar-2017)

3.8 m
Cesca Therapeutics's current market capitalization is $31.9 m.
USDFY, 2014FY, 2015FY, 2016


16 m16 m11.9 m

Revenue growth, %


Cost of goods sold

10.1 m11.3 m9.2 m

Gross profit

5.9 m4.7 m2.7 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


3.7 m4.6 m4 m2.8 m3.3 m2.8 m3.8 m4 m3.3 m

Cost of goods sold

2.5 m3.1 m2.9 m2.5 m2.3 m2.4 m2.4 m2.5 m1.9 m

Gross profit

1.2 m1.5 m1.1 m367 k1 m408 k1.4 m1.6 m1.4 m

Gross profit Margin, %

USDFY, 2014FY, 2015FY, 2016


14.8 m3.4 m5.8 m

Accounts Receivable

6.2 k


524 m

Current Assets

25.3 m13.3 m12.8 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


10.7 m8.4 m4.8 m6.6 m2.9 m7.2 m5.6 m4.9 m3.8 m


5.9 m5.2 m5 m4 m4 m3.5 m

Current Assets

21.5 m18.4 m15.7 m14.3 m10.7 m15.1 m12.2 m10.9 m10.6 m


13.3 m13.2 m13.2 m13.2 m13.2 m13.2 m13.2 m13.2 m13.2 m
USDFY, 2014FY, 2015FY, 2016

Net Income

(8.6 m)(14.9 m)(18.6 m)

Depreciation and Amortization

993 k1.4 m1.2 m

Accounts Receivable

(2.1 k)(487)2 m


6.4 k42.1 k
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(3.3 m)(4.4 m)(4.8 m)(3.4 m)(624 k)(10.9 m)(22.4 m)(3.4 m)(2.1 m)


5.9 m5.2 m5 m4 m4 m3.5 m

Accounts Payable

3 m3.2 m4.7 m5.7 m4.4 m3.3 m1.8 m2.1 m1.9 m
USDY, 2017


34.2 k

Financial Leverage

1.5 x
Show all financial metrics

Cesca Therapeutics Operating Metrics

FY, 2016

Patents Issued

Show all operating metrics

Cesca Therapeutics Market Value History

Cesca Therapeutics's Web-traffic and Trends

Cesca Therapeutics Online and Social Media Presence

Cesca Therapeutics Company Life and Culture

You may also be interested in